Abstract:Summary Background Molecular diagnosis is crucial for biomarker-assisted glioma resection and management. However, some limitations of current molecular diagnostic techniques prevent their widespread use intraoperatively. With the unique advantages of ultrasound, this study developed a rapid intraoperative molecular diagnostic method based on ultrasound radio-frequency signals. Methods We built a brain tumor ultrasound bank with 169 cases enrolled since July 2020, of which 43483 RF signal patches from 67 cases with a pathological diagnosis of glioma were a retrospective cohort for model training and validation. IDH1 and TERT promoter ( TERTp ) mutations and 1p/19q co-deletion were detected by next-generation sequencing. We designed a spatial–temporal integration model (STIM) to diagnose the three molecular biomarkers, thus establishing a rapid intraoperative molecular diagnostic system for glioma, and further analysed its consistency with the fifth edition of the WHO Classification of Tumors of the Central Nervous System (WHO CNS5). We tested STIM in 16-case prospective cohorts, which contained a total of 10384 RF signal patches. Two other RF-based classical models were used for comparison. Further, we included 20 cases additional prospective data for robustness test ( ClinicalTrials.gov NCT05656053 ). Findings In the retrospective cohort, STIM achieved a mean accuracy and AUC of 0.9190 and 0.9650 (95% CI, 0.94–0.99) respectively for the three molecular biomarkers, with a total time of 3 s and a 96% match to WHO CNS5. In the prospective cohort, the diagnostic accuracy of STIM is 0.85 ± 0.04 (mean ± SD) for IDH1 , 0.84 ± 0.05 for TERTp , and 0.88 ± 0.04 for 1p/19q. The AUC is 0.89 ± 0.02 (95% CI, 0.84–0.94) for IDH1 , 0.80 ± 0.04 (95% CI, 0.71–0.89) for TERTp , and 0.85 ± 0.06 (95% CI, 0.73–0.98) for 1p/19q. Compared to the second best available method based on RF signal, the diagnostic accuracy of STIM is improved by 16.70% and the AUC is improved by 19.23% on average. Interpretation STIM is a rapid, cost-effective, and easy-to-manipulate AI method to perform real-time intraoperative molecular diagnosis. In the future, it may help neurosurgeons designate personalized surgical plans and predict survival outcomes. Funding A full list of funding bodies that contributed to this study can be found in the Acknowledgements section.

Microfluidics for rapid detection of isocitrate dehydrogenase 1 mutation for intraoperative application.

Rapid detection of IDH mutations in gliomas by intraoperative mass spectrometry

Intraoperative detection of isocitrate dehydrogenase mutations in human gliomas using a miniature mass spectrometer

Rapid Diagnosis of IDH1-mutated Gliomas by 2-HG Detection with Gas Chromatography Mass Spectrometry.

Development of a Hydrogen Peroxide Fluorescent Probe for the Rapid Discrimination of IDH1 Mutant Gliomas from the Wild-type

Application of Intraoperative Rapid Molecular Diagnosis in Precision Surgery for Glioma: Mimic the World Health Organization CNS5 Integrated Diagnosis

Rapid Determination of Isocitrate Dehydrogenase Mutation Status of Human Gliomas by Extraction Nanoelectrospray Using a Miniature Mass Spectrometer

Detection of the IDH1/2 Gene Mutations in Tumor Samples with Low-Abundance Mutant Allele

A biosensor for D-2-hydroxyglutarate in frozen sections and intraoperative assessment of IDH mutation status

Innv-10. Ultra-Rapid Intraoperative Glioma Tumor Cell Quantification

Rapid extraction-free detection of the R132H isocitrate dehydrogenase mutation in glioma using colorimetric peptide nucleic acid-loop mediated isothermal amplification (CPNA-LAMP)

IDH1 Mutation Detection by Droplet Digital PCR in Glioma.

PATH-44. INTRA-OPERATIVE ANALYSES OF GENETIC ALTERATIONS IN THE CENTRAL NERVOUS SYSTEM TUMORS USING RAPID QUANTITATIVE PCR DEVICE

Path-49. Intra-Operative Genetic Analyses For Decision-Making During Tumor Removal Of Adult-Type Diffuse Glioma Using Rapid Quantitative Pcr Device

Rapid intraoperative multi-molecular diagnosis of glioma with ultrasound radio frequency signals and deep learning

Preliminary Establishment of High Resolution Melting Analysis for Detecting IDH1 Gene Mutations in Gliomas

Absolute quantification of 2-hydroxyglutarate on tissue by matrix-assisted laser desorption/ionization mass spectrometry imaging for rapid and precise identification of isocitrate dehydrogenase mutations in human glioma

Evaluation of the rapid Idylla IDH1-2 mutation assay in FFPE glioma samples

Predicting IDH mutation status as well as Ki-67 and p53 expression in high-grade gliomas using amide proton transfer-weighted and arterial spin labeling MRI

TAMI-09. INTRAOPERATIVE MICRODIALYSIS AS A FEASIBLE PLATFORM FOR METABOLIC AND PHARMACODYNAMIC BIOMARKER DISCOVERY

Intraoperative rapid immunohistochemistry of microsatellite instability using non-contact alternating current electric field mixing